跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 48 条关于
“Anaveon”
全部
48
临床试验
16
药物
16
机构
4
资讯
12
4个月前
Anaveon Presents Positive ANV600 Clinical Data at ASCO 2026, Seeks Partners for Oncology Portfolio
上个月
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board ahead of clinical-stage transition
去年
IL-2 Inhibitor Pipeline Expands with 20+ Companies Developing 22+ Therapeutic Candidates
去年
Anavex Completes Enrollment in Phase 2 Trial of ANAVEX®3-71 for Schizophrenia Treatment
11个月前
Anavex Reports Positive Phase 2 Results for ANAVEX®3-71 in Schizophrenia and Successful Once-Daily Formulation Development
去年
Anavex Life Sciences Awaits Topline Results from Rett Syndrome Trial
去年
Anavex Life Sciences Reports Financial Results and Clinical Advancements in Neurodegenerative Disease Research
去年
Anavex's ANAVEX3-71 Shows Promise in Schizophrenia Phase 2 Trial with EEG Biomarker Improvements
去年
Anavex Life Sciences Announces EMA Acceptance of Blarcamesine MAA for Alzheimer's Treatment
去年
Neurology News: ShiraTronics' Migraine Device Trial, QurAlis' ALS Therapy, and Anavex's Alzheimer's Drug Application
第 1 页,共 2 页
上一页
下一页